Pacifico Biolabs raises €7M to turn brewery infrastructure into protein production
PacificoBiolabs, a mycelium fermentation protein company, has raised €7 million in aSeries A funding round backed by Stray Dog Capital, TGFS, Sprout & AboutVentures, Simon Capital, FoodLabs, and a...
Rising demand for sustainable protein alternatives and advancements in biotechnology are making mycelium fermentation an increasingly viable and attractive investment for food production.
This funding round indicates growing investor confidence in synthetic biology applications for food, potentially accelerating the shift away from traditional animal agriculture and mitigating environmental impacts.
The capital infusion allows Pacifico Biolabs to scale its protein production by leveraging existing brewery infrastructure, demonstrating an innovative and resource-efficient approach to industrial biotech.
- · Pacifico Biolabs
- · Alternative protein sector
- · Biotech investors
- · Brewery infrastructure owners
- · Traditional meat producers
- · Legacy food processing companies
- · Dairy industry
Increased availability and affordability of mycelium-based protein products enter the market.
Other food and beverage companies begin exploring similar 'circular economy' models, repurposing existing industrial facilities for novel food production.
Established food ingredient suppliers face pressure to innovate or partner with synthetic biology startups to remain competitive.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at Tech.eu